Mihail Obrocea - 08 Mar 2023 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Chief Medical Officer
Signature
/s/ Mihail Obrocea
Issuer symbol
MAIA
Transactions as of
08 Mar 2023
Transactions value $
$0
Form type
4
Date filed
10 Mar 2023, 16:06
Previous filing
20 Sep 2022
Next filing
05 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +100K $0.00 100K 08 Mar 2023 Common Stock 100K $4.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on March 8, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months.